MGRC executive director Datuk Alvin Joseph Nesakumar
KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
’s (MGRC) wholly owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRC-T) has entered into a cooperation agreement with the National Institutes of Health, Malaysia (NIH), providing a framework for collaboration between the two parties in medical research.
NIH, the research arm under the Health Ministry, comprises six research institutes that focus on biomedical research, public health and epidemiology, clinical research, behavioural health research, health management and health policies.
MGRC executive director Datuk Alvin Joseph Nesakumar said: “The cooperation agreement enables us to explore ways that we can work together with NIH to improve the quality of our genomics and biopharmaceutical services that can contribute to improving the health of the Rakyat.”
“We consider this collaboration a good step in encouraging and promoting research in genomics and biopharmaceuticals that will be mutually beneficial.”
Under this agreement, the parties will explore joint training in the field of medical research, exchange research materials, and partake in scientific data presentation and publication.
Additionally, the agreement will enable the exchange of experts and personnel, including postgraduate research and students on adjunct appointments, short- and long-term research attachments, co-supervision of students conducting research and internships, as well as other areas of cooperation to be mutually decided.
